NASDAQ:VIVO
Delisted
Meridian Bioscience Inc. Stock News
$33.97
+0 (+0%)
At Close: Apr 28, 2023
4 Stocks With High Net Income Ratio to Scoop Up
09:02am, Thursday, 07'th Jan 2021
Investors always look for companies with a high level of profitability regardless of the ongoing market condition.
Bet on Rising P/E With These 5 Top-Ranked Stocks
09:47am, Wednesday, 06'th Jan 2021
Want to try some out-of-the-box approach? Tap five stocks with increasing P/E ratios.
Meridian Bioscience to Participate in H. C. Wainright Bioconnect 2021 Virtual Conference
09:30am, Wednesday, 06'th Jan 2021
CINCINNATI, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) a provider of diagnostic testing solutions and life science raw materials, announced today its participation in t
Can Meridian Bioscience (VIVO) Run Higher on Rising Earnings Estimates?
01:32pm, Tuesday, 05'th Jan 2021
Meridian Bioscience (VIVO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Is Meridian Bioscience (VIVO) Outperforming Other Medical Stocks This Year?
12:02pm, Thursday, 31'st Dec 2020
Is (VIVO) Outperforming Other Medical Stocks This Year?
Top Stock Picks for Week of December 28, 2020
04:33pm, Tuesday, 29'th Dec 2020
Two Stocks With an Upward Moving Earnings Outlook.
These 3 Stocks Could Turn Your $600 Stimulus Check Into Much More
06:55am, Tuesday, 29'th Dec 2020
These stocks offer a mix of speculation and steady growth.
6 Top-Rated Stocks With Solid Net Profit Margin
09:02am, Monday, 28'th Dec 2020
Here are six best-performing stocks with substantial net profit margins that can contribute toward making an enriching portfolio.
A Trio of Stocks With a Record of Sales and Earnings Growth
12:00pm, Wednesday, 23'rd Dec 2020
In my opinion, investors may want to consider the three stocks that are listed in this article, since they could meet the following value criteria:
Meridian Bioscience receives NIH Award for supporting rapid development of Revogene® molecular test for SARS-CoV-2
03:00pm, Wednesday, 16'th Dec 2020
CINCINNATI, Dec. 16, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced that it has been awar
Meridian Bioscience submits application to FDA for Emergency Use Authorization for SARS-CoV-2 molecular assay
10:17am, Tuesday, 08'th Dec 2020
CINCINNATI, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced that it has submitted
CINCINNATI, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that i
Meridian Bioscience Participates in Piper Sandler 32nd Annual Virtual Healthcare Conference
10:00am, Monday, 23'rd Nov 2020
CINCINNATI, Nov. 23, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today its participation in the Piper Sandler 32nd Annual Virtual Healthcare Conference. Jack Kenny, Chi
Has Meridian Bioscience (VIVO) Outpaced Other Medical Stocks This Year?
11:30am, Tuesday, 17'th Nov 2020
Is (VIVO) Outperforming Other Medical Stocks This Year?
Meridian Bioscience to Participate in Canaccord Genuity Virtual MedTech & Diagnostics Forum
12:00pm, Monday, 16'th Nov 2020
CINCINNATI, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today that Jack Kenny, Chief Executive Officer, and Bryan Baldasare, Executive Vice President and Chief
